Coldstream Capital Management Inc Regenxbio Inc. Put Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RGNX
# of Institutions
180Shares Held
44.6MCall Options Held
64.9KPut Options Held
103K-
Black Rock Inc. New York, NY8.61MShares$84 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.79MShares$46.8 Million3.6% of portfolio
-
Jpmorgan Chase & CO New York, NY4.36MShares$42.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$33.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$20.2 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $422M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...